Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 1-4

  Durham, Megan M ^a   Bingaman, Adam W ^a   Adams, Andrew B ^a   Ha, Jongwon ^a,b   Waitze, Seung Yeun ^a   Pearson, Thomas C ^a,c   Larsen, Christian P ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c Carlos Marguerite Mason T   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; LIGAND;

ALLOGENEIC RESTRICTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHIMERA; CONTROLLED STUDY; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE; TRANSPLANTATION;

EID: 0034235458     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.1     Document Type: Article

References (10)

1. Stewart, F. M., R. B. Crittenden, P. A. Lowry, S. Pearson-White, and P. J. Quesenberry. 1993. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81:2566.
2. Down, J. D., N. J. Tarbell, H. D. Thames, and P. M. Mauch. 1991. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood 77:661.
3. Tomita, Y., D. H. Sachs, and M. Sykes. 1994. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 83:939.
4. Quesenberry, P. J., R. B. Crittenden, P. Lowry, E. W. Kittler, S. Rao, S. Peters, H. Ramshaw, and F. M. Stewart. 1994. In vitro and in vivo studies of stromal niches. Blood Cells 20:97.
5. Rao, S. S., S. O. Peters, R. B. Crittenden, F. M. Stewart, H. S. Ramshaw, and P. J. Quesenberry. 1997. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp. Hematol. 25:114.
6. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hodes, R. P. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208.
7. Dyson, P. J., A. M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of VB11 T cells cosegregate with mammary tumour virus genomes. Nature 349:531.
8. Bill, J., O. Kanagawa, D. L. Woodland, and E. Palmer. 1989. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of VβI1-bearing T cells. J. Exp. Med. 169:1405.
9. Wekerle, T., M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M. Sykes, 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187:2037.
10. + T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101:2446.